GNTA

Genenta Science S.p.A.

Price Chart

No historical data available

Latest Quote

$1.00

+0.01 (+0.94%)

Current Price

Previous Close	$0.99
Open	$1.02
Day High	$1.08
Day Low	$1.00
Volume	57,762

Fetched: 2026-08-31T04:06:42

Stock Information

Note: Financial values converted from EUR to USD

Shares Outstanding	48.22M
Total Debt	$8.82M
Cash Equivalents	$32.64M
Net Income	$-7.57M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$48.22M
EPS (TTM)	$-0.38
Exchange	NCM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Genenta Science S.p.A.

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

📰 Latest News

No news articles available at the moment. Check back later for updates on GNTA.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Total Expenses	$7,657,398	$11,322,252	$13,604,988	$12,806,113
Other Income Expense	$-619,892	$893,640	$-257,150	$2,932,797
Other Non Operating Income Expenses	$13,284	$614,196	$-5,653	$281,255
Net Non Operating Interest Income Expense	$705,598	$94,086	$358,596	$42,886
Operating Expense	$7,657,398	$11,322,252	$13,604,988	$12,806,113
General And Administrative Expense	$4,527,363	$5,741,484	$6,097,520	$6,615,294
Total Other Finance Cost	-	-	$-358,596	$-42,886
Interest Expense	-	-	-	-
Interest Expense Non Operating	-	-	-	-
Other Operating Expenses	-	-	-	-
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-7,571,692	$-10,334,525	$-13,503,542	$-9,830,430
Net Interest Income	$705,598	$94,086	$358,596	$42,886
Interest Income	$705,598	$94,086	$358,596	$42,886
Normalized Income	$-6,938,516	$-10,613,969	$-13,252,045	$-12,481,972
Net Income From Continuing And Discontinued Operation	$-7,571,692	$-10,334,525	$-13,503,542	$-9,830,430
Total Operating Income As Reported	$-7,657,398	$-11,322,252	$-13,604,988	$-12,806,113
Net Income Common Stockholders	$-7,571,692	$-10,334,525	$-13,503,542	$-9,830,430
Net Income	$-7,571,692	$-10,334,525	$-13,503,542	$-9,830,430
Net Income Including Noncontrolling Interests	$-7,571,692	$-10,334,525	$-13,503,542	$-9,830,430
Net Income Continuous Operations	$-7,571,692	$-10,334,525	$-13,503,542	$-9,830,430
Pretax Income	$-7,571,692	$-10,334,525	$-13,503,542	$-9,830,430
Interest Income Non Operating	$705,598	$94,086	$358,596	$42,886
Operating Income	$-7,657,398	$-11,322,252	$-13,604,988	$-12,806,113
Per Share
Diluted EPS	$-0.38	$-0.57	$-0.74	$-0.54
Basic EPS	$-0.38	$-0.57	$-0.74	$-0.54
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-6,991,659	$-11,550,068	$-13,304,264	$-15,450,535
Total Unusual Items	$-633,176	$279,443	$-251,497	$2,651,542
Total Unusual Items Excluding Goodwill	$-633,176	$279,443	$-251,497	$2,651,542
Reconciled Depreciation	$32,563	$51,627	$49,227	$7,120
EBITDA (Bullshit earnings)	$-7,624,835	$-11,270,625	$-13,555,761	$-12,798,993
EBIT	$-7,657,398	$-11,322,252	$-13,604,988	$-12,806,113
Diluted Average Shares	$22,855,040	$21,189,111	$21,123,500	$21,123,443
Basic Average Shares	$22,855,040	$21,189,111	$21,123,500	$21,123,443
Diluted NI Availto Com Stockholders	$-7,571,692	$-10,334,525	$-13,503,542	$-9,830,430
Tax Provision	$0	$0	$0	$0
Gain On Sale Of Security	$-633,176	$279,443	$-251,497	$2,651,542
Research And Development	$3,130,035	$5,580,767	$7,507,468	$6,190,818
Selling General And Administration	$4,527,363	$5,741,484	$6,097,520	$6,615,294
Other Gand A	$2,205,105	$2,846,655	$3,132,216	$2,186,536
Insurance And Claims	$24,137	$21,038	$25,407	$1,456,989
Salaries And Wages	$2,298,120	$2,873,792	$2,939,897	$2,971,769

Fetched: 2026-08-31

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$25,325,417	$14,489,455	$23,692,320	$36,106,407
Total Assets	$36,977,399	$17,189,231	$25,912,737	$38,773,028
Total Non Current Assets	$2,214,469	$407,022	$1,264,943	$1,990,366
Other Non Current Assets	$5,227	$20,807	$244,165	$49,199
Non Current Accounts Receivable	$2,183,192	$336,445	$924,562	$1,811,716
Current Assets	$34,762,930	$16,782,209	$24,647,794	$36,782,661
Other Current Assets	$391,278	$244,469	$74,981	$254,406
Prepaid Assets	$240,369	$178,554	$478,033	$167,775
Receivables	$1,490,758	$1,679,512	$2,323,323	$1,811,715
Taxes Receivable	$1,490,758	$1,679,512	$2,323,323	$1,811,715
Cash Cash Equivalents And Short Term Investments	$32,640,526	$14,679,674	$21,771,456	$34,548,765
Cash And Cash Equivalents	$6,409,638	$5,312,789	$4,280,403	$34,548,765
Cash Financial	$6,409,638	$5,312,789	$4,280,403	$34,548,765
Current Deferred Assets	-	-	-	-
Debt
Net Debt	$2,406,456	-	-	-
Total Debt	$8,816,094	-	-	-
Long Term Debt And Capital Lease Obligation	$8,816,094	-	-	-
Long Term Debt	$8,816,094	-	-	-
Liabilities
Total Liabilities Net Minority Interest	$11,651,983	$2,699,776	$2,220,417	$2,666,621
Total Non Current Liabilities Net Minority Interest	$9,196,179	$265,451	$207,849	$134,718
Current Liabilities	$2,455,804	$2,434,325	$2,012,568	$2,531,903
Other Current Liabilities	$137,987	$391,656	$295,758	$345,402
Payables And Accrued Expenses	$2,317,816	$2,042,669	$1,716,810	$2,186,500
Payables	$2,098,324	$577,396	$540,194	$1,384,557
Accounts Payable	$1,750,078	$368,541	$342,040	$1,208,319
Other Non Current Liabilities	-	$1,343	$16,923	$31,561
Equity
Common Stock Equity	$25,325,417	$14,489,455	$23,692,320	$36,106,407
Total Equity Gross Minority Interest	$25,325,417	$14,489,455	$23,692,320	$36,106,407
Stockholders Equity	$25,325,417	$14,489,455	$23,692,320	$36,106,407
Gains Losses Not Affecting Retained Earnings	$193,079	$103,138	$268,022	$0
Other Equity Adjustments	$193,079	$103,138	$268,022	-
Retained Earnings	$-72,571,133	$-64,999,442	$-54,664,916	$-41,124,256
Other
Ordinary Shares Number	$27,170,898	$21,208,100	$21,123,559	$21,123,443
Share Issued	$27,170,898	$21,208,100	$21,123,559	$21,123,443
Tangible Book Value	$25,325,417	$14,489,455	$23,692,320	$36,106,407
Invested Capital	$34,141,511	$14,489,455	$23,692,320	$36,106,407
Working Capital	$32,307,127	$14,347,883	$22,635,226	$34,250,759
Total Capitalization	$34,141,511	$14,489,455	$23,692,320	$36,106,407
Capital Stock	$97,703,471	$79,385,759	$78,089,214	$77,230,662
Common Stock	$97,703,471	$79,385,759	$78,089,214	$77,230,662
Employee Benefits	$380,085	$264,108	$190,926	$103,157
Non Current Pension And Other Postretirement Benefit Plans	$380,085	$264,108	$190,926	$103,157
Current Accrued Expenses	$219,492	$1,465,274	$1,176,616	$801,943
Dueto Related Parties Current	$348,247	$208,854	$198,154	$176,238
Net PPE	$26,049	$49,770	$96,216	$129,452
Accumulated Depreciation	$-146,574	$-114,011	$-62,383	$-14,082
Gross PPE	$172,623	$163,781	$158,599	$143,533
Other Properties	$70,814	$61,972	$56,790	-
Machinery Furniture Equipment	$101,809	$101,809	$101,809	$143,533
Other Short Term Investments	$26,230,888	$9,366,885	$17,491,052	$0
Additional Paid In Capital	-	-	$0	$0

Fetched: 2026-08-31

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-7,972,616	$-7,241,004	$-13,008,829	$-8,633,240
Operating Activities
Operating Cash Flow	$-7,963,774	$-7,235,823	$-12,992,837	$-8,601,850
Cash Flow From Continuing Operating Activities	$-7,963,774	$-7,235,823	$-12,992,837	$-8,601,850
Operating Gains Losses	$115,976	$73,182	$87,769	$104,772
Investing Activities
Capital Expenditure	$-8,842	$-5,181	$-15,991	$-31,389
Investing Cash Flow	$-16,864,489	$7,981,289	$-17,268,861	$-31,389
Cash Flow From Continuing Investing Activities	$-16,864,489	$7,981,289	$-17,268,861	$-31,389
Financing Activities
Financing Cash Flow	$25,843,527	$314,106	$616	$0
Cash Flow From Continuing Financing Activities	$25,843,527	$314,106	$616	$0
Net Other Financing Charges	$17,146,866	$314,106	$616	-
Issuance Of Capital Stock	-	-	$616	$0
Net Common Stock Issuance	-	-	$616	$0
Common Stock Issuance	-	-	$616	$0
Other
Issuance Of Debt	$8,696,660	$0	$0	-
End Cash Position	$6,409,638	$5,312,789	$4,280,403	$34,548,765
Beginning Cash Position	$5,312,789	$4,280,403	$34,548,765	$43,182,005
Effect Of Exchange Rate Changes	$81,586	$-27,187	$-7,280	$0
Changes In Cash	$1,015,263	$1,059,572	$-30,261,082	$-8,633,240
Net Issuance Payments Of Debt	$8,696,660	$0	$0	-
Net Long Term Debt Issuance	$8,696,660	$0	$0	-
Long Term Debt Issuance	$8,696,660	$0	$0	-
Net Investment Purchase And Sale	$-16,855,648	$7,986,470	$-17,252,869	$0
Sale Of Investment	$21,601,131	$26,980,397	$0	$0
Purchase Of Investment	$-38,456,779	$-18,993,927	$-17,252,869	$0
Net PPE Purchase And Sale	$-8,842	$-5,181	$-15,991	$-31,389
Purchase Of PPE	$-8,842	$-5,181	$-15,991	$-31,389
Change In Working Capital	$-1,830,902	$1,991,455	$-484,227	$278,638
Change In Other Current Liabilities	$-255,012	$80,318	$-64,282	$260,174
Change In Other Current Assets	$-1,831,168	$811,475	$692,188	$-496,180
Change In Payables And Accrued Expense	$275,147	$325,859	$-469,690	$987,150
Change In Accrued Expense	$-1,245,782	$288,657	$374,673	$-177,247
Change In Payable	$1,520,929	$37,202	$-844,363	$1,164,397
Change In Account Payable	$1,520,929	$37,202	$-844,363	$1,164,397
Change In Prepaid Assets	$-19,870	$773,803	$-642,442	$-472,506
Stock Based Compensation	$1,170,846	$982,439	$857,936	$838,051
Unrealized Gain Loss On Investment Securities	$119,434	$0	$0	-
Depreciation Amortization Depletion	$32,563	$51,627	$49,227	$7,120
Depreciation And Amortization	$32,563	$51,627	$49,227	$7,120
Depreciation	$32,563	$51,627	$49,227	$7,120
Pension And Employee Benefit Expense	$115,976	$73,182	$87,769	$67,653
Net Income From Continuing Operations	$-7,571,692	$-10,334,525	$-13,503,542	$-9,830,430
Net Foreign Currency Exchange Gain Loss	-	$0	$0	$37,119
Proceeds From Stock Option Exercised	-	-	$0	$0
Other Non Cash Items	-	-	-	$37,119

Fetched: 2026-08-31